Project Details
Description
MRFF Rare Cancers, Rare Diseases and Unmet Need - Neuroligical Disorders
| Acronym | SEL003 |
|---|---|
| Status | Active |
| Effective start/end date | 15/08/24 → 13/03/29 |
A Phase 2 Randomised Controlled Trial of Sodium Selenate as a Disease Modifying Treatment for Probable Progressive Supranuclear Palsy
- O'Brian, Terence (Chief Investigator)
- Lewis, Simon (Primary Chief Investigator)
- West, Stacey (Other)
- Harvey, Caroline (Other)
Project: Research